Trial Profile
Study of romiplostim for treatment of chronic immune thrombocytopenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Aug 2018
Price :
$35
*
At a glance
- Drugs Romiplostim (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Adverse reactions; Therapeutic Use
- 06 Aug 2018 New trial record
- 17 Jun 2018 Results presented at the 23rd Congress of the European Haematology Association